Viswanathan Gajendran, MD - Medicare Urology in Roseville, CA

Viswanathan Gajendran, MD is a medicare enrolled "Urology" physician in Roseville, California. His current practice location is 1600 Eureka Rd, Roseville, California. You can reach out to his office (for appointments etc.) via phone at (916) 784-4000.

Viswanathan Gajendran is licensed to practice in California (license number A69056) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1053499731.

Contact Information

Viswanathan Gajendran, MD
1600 Eureka Rd,
Roseville, CA 95661-3027
(916) 784-4000
Not Available



Physician's Profile

Full NameViswanathan Gajendran
GenderMale
SpecialityUrology
Location1600 Eureka Rd, Roseville, California
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1053499731
  • Provider Enumeration Date: 11/01/2006
  • Last Update Date: 07/08/2007
  Medicare PECOS Information:
  • PECOS PAC ID: 7416144043
  • Enrollment ID: I20101208001282

Medical Identifiers

Medical identifiers for Viswanathan Gajendran such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1053499731NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208800000XUrology A69056 (California)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Viswanathan Gajendran allows following entities to bill medicare on his behalf.
Entity NamePermanente Medical Group Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1073606299
PECOS PAC ID: 8921910225
Enrollment ID: O20031104000710

News Archive

Top-line results from Genzyme's teriflunomide and Rebif Phase III comparison trial on RMS

Genzyme, a Sanofi company, today reported top-line results from TENERE, a Phase III clinical trial comparing the effectiveness, safety and tolerability of once-daily oral teriflunomide to interferon beta-1a, an approved injectable therapy, in people with relapsing forms of multiple sclerosis.

Study reveals link between composition of intestinal microbiota and cognitive performance

Since 2006, several studies have shown that morbid obesity is associated with impaired immediate and recent memory.

State roundup: Surging number of high-deductible health plans; Mass. contemplates physician-assisted 'suicide'; Costs slowing in Colo.

High-deductible health insurance plans are catching on in states struggling to contain escalating costs among their own employees, according to a brief the National Governors Association released Thursday. Nationally, insurance industry figures show that 13.5 million workers - public and private - are enrolled in high-deductible plans, which have soared in popularity in recent years among private sector employers trying to cope with high costs. The idea is that health costs will decline because workers will have more of an incentive to look for the best value in health care.

Inhibitor compounds could form basis of new treatments for such diseases as MRSA, anthrax

​Inhibitor compounds developed by UC Irvine structural biologists and Northwestern University chemists have been shown to bolster the ability of antibiotics to treat deadly bacterial diseases such as MRSA and anthrax.

Read more Medical News

› Verified 3 days ago

Entity NameRegents Of The Univ Of Ca
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1013906973
PECOS PAC ID: 3375456619
Enrollment ID: O20031111000892

News Archive

Top-line results from Genzyme's teriflunomide and Rebif Phase III comparison trial on RMS

Genzyme, a Sanofi company, today reported top-line results from TENERE, a Phase III clinical trial comparing the effectiveness, safety and tolerability of once-daily oral teriflunomide to interferon beta-1a, an approved injectable therapy, in people with relapsing forms of multiple sclerosis.

Study reveals link between composition of intestinal microbiota and cognitive performance

Since 2006, several studies have shown that morbid obesity is associated with impaired immediate and recent memory.

State roundup: Surging number of high-deductible health plans; Mass. contemplates physician-assisted 'suicide'; Costs slowing in Colo.

High-deductible health insurance plans are catching on in states struggling to contain escalating costs among their own employees, according to a brief the National Governors Association released Thursday. Nationally, insurance industry figures show that 13.5 million workers - public and private - are enrolled in high-deductible plans, which have soared in popularity in recent years among private sector employers trying to cope with high costs. The idea is that health costs will decline because workers will have more of an incentive to look for the best value in health care.

Inhibitor compounds could form basis of new treatments for such diseases as MRSA, anthrax

​Inhibitor compounds developed by UC Irvine structural biologists and Northwestern University chemists have been shown to bolster the ability of antibiotics to treat deadly bacterial diseases such as MRSA and anthrax.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Viswanathan Gajendran is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Viswanathan Gajendran, MD
1800 Harrison St Fl 7,
Oakland, CA 94612-3429

Ph: (510) 625-6262
Viswanathan Gajendran, MD
1600 Eureka Rd,
Roseville, CA 95661-3027

Ph: (916) 784-4000

News Archive

Top-line results from Genzyme's teriflunomide and Rebif Phase III comparison trial on RMS

Genzyme, a Sanofi company, today reported top-line results from TENERE, a Phase III clinical trial comparing the effectiveness, safety and tolerability of once-daily oral teriflunomide to interferon beta-1a, an approved injectable therapy, in people with relapsing forms of multiple sclerosis.

Study reveals link between composition of intestinal microbiota and cognitive performance

Since 2006, several studies have shown that morbid obesity is associated with impaired immediate and recent memory.

State roundup: Surging number of high-deductible health plans; Mass. contemplates physician-assisted 'suicide'; Costs slowing in Colo.

High-deductible health insurance plans are catching on in states struggling to contain escalating costs among their own employees, according to a brief the National Governors Association released Thursday. Nationally, insurance industry figures show that 13.5 million workers - public and private - are enrolled in high-deductible plans, which have soared in popularity in recent years among private sector employers trying to cope with high costs. The idea is that health costs will decline because workers will have more of an incentive to look for the best value in health care.

Inhibitor compounds could form basis of new treatments for such diseases as MRSA, anthrax

​Inhibitor compounds developed by UC Irvine structural biologists and Northwestern University chemists have been shown to bolster the ability of antibiotics to treat deadly bacterial diseases such as MRSA and anthrax.

Read more News

› Verified 3 days ago


Urology Doctors in Roseville, CA

Dr. Hossein Mirheydar, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 3 Medical Plaza Dr, Ste 250, Roseville, CA 95661
Phone: 916-797-4720    
Mr. Abdo J. Faddoul, M.D.
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 2 Medical Plaza, Suite 285, Roseville, CA 95661
Phone: 916-786-3100    Fax: 916-786-9433
George W. Chiu, MD
Urology
Medicare: Medicare Enrolled
Practice Location: 1600 Eureka Rd, Roseville, CA 95661
Phone: 916-784-4000    
John E Gould, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 1130 Conroy Ln, Suite 100, Roseville, CA 95661
Phone: 916-773-5529    Fax: 916-773-0430
Dr. Carolina Raveau Alvayay, M.D.
Urology
Medicare: Accepting Medicare Assignments
Practice Location: 3 Medical Plaza Dr, Suite 250, Roseville, CA 95661
Phone: 916-797-4719    Fax: 916-797-4721
William Hoch, M.D.
Urology
Medicare: Not Enrolled in Medicare
Practice Location: 2261 Douglas Blvd, Roseville, CA 95661
Phone: 916-783-7109    Fax: 916-783-2882

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.